Skip to Main Content

Paper Details

Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy.
Sci Transl Med
69
2017
3-nitropropionic acid, Anti-, Tau, Tauopathies, anti-tau, anti-tau antibodies, anti-tau antibody, cytosolic protein tau, human, human tau, human tau transgenic, interstitial, mice, mouse, mouse plasma, neurodegeneration, patients, tau, tau antibody, tauopathies, tauopathy
Author NameAffiliation
Jason D UlrichHope Center for Neurological Disorders and Knight Alzheimer's Disease Research Center, Washington University
Adam L BoxerClinical Trials Program, University of California san francisco
Bruce L MillerClinical Trials Program, University of California san francisco
Diana R KerwinTexas Health Presbyterian Hospital Dallas
Nigel J CairnsHope Center for Neurological Disorders and Knight Alzheimer's Disease Research Center, Washington University
David M HoltzmanHope Center for Neurological Disorders and Knight Alzheimer's Disease Research Center, Washington University
  • 1 - 6

Datasets

Release 1.2